{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:17:27Z","timestamp":1788560247756,"version":"build-2803163510"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.anl.2023.08.006","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T23:55:46Z","timestamp":1693094146000},"page":"391-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Translational research in head and neck cancer: Molecular and immunological updates"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-671X","authenticated-orcid":false,"given":"Takumi","family":"Kumai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-7545","authenticated-orcid":false,"given":"Hirotaka","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-9456","authenticated-orcid":false,"given":"Hirofumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3783-9961","authenticated-orcid":false,"given":"Hideaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0590-3965","authenticated-orcid":false,"given":"Toshihiro","family":"Kishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeharu","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2023.08.006_bib0001","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2013systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.08.006_bib0002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jnci\/djad025","article-title":"Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?","volume":"115","author":"Castle","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anl.2023.08.006_bib0003","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0194-59989770326-7","article-title":"Head and neck cancer screening among 4611 tobacco users older than forty years","volume":"116","author":"Prout","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2023.08.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106072","article-title":"Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival","volume":"134","author":"Krutz","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0005","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1002\/cncr.33628","article-title":"Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030","volume":"127","author":"Wu","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0006","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ((10)B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0007","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/hed.25618","article-title":"Feasibility of carbon-ion radiotherapy for oral non-squamous cell carcinomas","volume":"41","author":"Ikawa","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.08.006_bib0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/lary.26796","article-title":"Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer","volume":"128","author":"Sethia","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2023.08.006_bib0009","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/hed.26047","article-title":"Endoscopic resection of sinonasal malignancies","volume":"42","author":"Abdelmeguid","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.08.006_bib0010","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/jjco\/hyaa139","article-title":"Immunotherapy for squamous cell carcinoma of the head and neck","volume":"50","author":"Yokota","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0011","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/thy.2016.0549","article-title":"Defining Radioiodine-Refractory Differentiated Thyroid Cancer: efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial","volume":"27","author":"Kiyota","year":"2017","journal-title":"Thyroid."},{"key":"10.1016\/j.anl.2023.08.006_bib0013","article-title":"Larotrectinib treatment for patients with TRK fusion-positive salivary gland cancers","author":"Le","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.anl.2023.08.006_bib0014","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa2005493","article-title":"Five-year analysis of adjuvant dabrafenib plus trametinib in stage III melanoma","volume":"383","author":"Dummer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2023.08.006_bib0016","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225662","article-title":"Near-infrared photoimmunotherapy for oropharyngeal cancer","volume":"14","author":"Nishikawa","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2023.08.006_bib0018","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2326-6066.CIR-18-0546","article-title":"Host immunity following near-infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established antigenic tumors","volume":"7","author":"Nagaya","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0019","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-19-0517","article-title":"Combined CD44- and CD25-targeted near-infrared photoimmunotherapy selectively kills cancer and regulatory T cells in syngeneic mouse cancer models","volume":"8","author":"Maruoka","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0020","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0021","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2152248","article-title":"Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response","volume":"11","author":"Kato","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.anl.2023.08.006_bib0022","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"Mody","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2023.08.006_bib0023","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.aag0299","article-title":"Mutational signatures associated with tobacco smoking in human cancer","volume":"354","author":"Alexandrov","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.anl.2023.08.006_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1110(88)90013-9","article-title":"A mutagenicity assessment of acetaldehyde","volume":"195","author":"Dellarco","year":"1988","journal-title":"Mutat Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/carcin\/bgl206","article-title":"Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma","volume":"28","author":"Asakage","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.anl.2023.08.006_bib0026","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12263-009-0154-1","article-title":"Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism","volume":"5","author":"Seitz","year":"2010","journal-title":"Genes Nutr"},{"key":"10.1016\/j.anl.2023.08.006_bib0027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0028","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000485322","article-title":"High-risk human papillomavirus in oral cancer: clinical implications","volume":"94","author":"Yete","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.anl.2023.08.006_bib0029","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0030","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.anl.2023.08.006_bib0031","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.anl.2023.08.006_bib0032","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/febs.14061","article-title":"3q26-29 amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes","volume":"284","author":"Davidson","year":"2017","journal-title":"Febs j"},{"key":"10.1016\/j.anl.2023.08.006_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.813732","article-title":"EGFR mutation and 11q13 amplification are potential predictive biomarkers for immunotherapy in head and neck squamous cell carcinoma","volume":"13","author":"Dou","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.anl.2023.08.006_bib0034","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/labinvest.2015.163","article-title":"Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma","volume":"96","author":"Lee","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.anl.2023.08.006_bib0035","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.aax0902","article-title":"Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling","volume":"367","author":"Loganathan","year":"2020","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.anl.2023.08.006_bib0036","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ncponc0354","article-title":"DNA methylation and gene silencing in cancer","volume":"2","author":"Baylin","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0037","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1159\/000494473","article-title":"The association and clinical significance of CDKN2A promoter methylation in head and neck squamous cell carcinoma: a meta-analysis","volume":"50","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.anl.2023.08.006_bib0038","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15592294.2015.1048953","article-title":"Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors","volume":"10","author":"Chen","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.anl.2023.08.006_bib0039","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/ijc.32890","article-title":"Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes","volume":"146","author":"Nakagawa","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.anl.2023.08.006_bib0041","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41467-018-04449-5","article-title":"In vivo reprogramming drives Kras-induced cancer development","volume":"9","author":"Shibata","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.anl.2023.08.006_bib0042","doi-asserted-by":"crossref","first-page":"eaay3324","DOI":"10.1126\/sciadv.aay3324","article-title":"YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma","volume":"6","author":"Omori","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.anl.2023.08.006_bib0043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.oraloncology.2018.02.014","article-title":"Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway","volume":"79","author":"Garc\u00eda-Escudero","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0044","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anl.2023.08.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144056","article-title":"Primary tumor-secreted lymphangiogenic factors induce pre-metastatic lymphvascular niche formation at sentinel lymph nodes in oral squamous cell carcinoma","volume":"10","author":"Wakisaka","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.anl.2023.08.006_bib0046","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0047","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/1078-0432.CCR-10-2120","article-title":"Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro","volume":"17","author":"Sano","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0048","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106270","article-title":"Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma","volume":"136","author":"Mito","year":"2023","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0050","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.anl.2023.08.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262549","article-title":"Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma","volume":"17","author":"Suzuki","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.anl.2023.08.006_bib0052","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00262-015-1742-0","article-title":"Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma","volume":"64","author":"Takahashi","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.anl.2023.08.006_bib0053","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148960","article-title":"Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment","volume":"7","author":"Oo","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.anl.2023.08.006_bib0054","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.anl.2023.08.006_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.anl.2023.08.006_bib0056","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/ijc.32061","article-title":"Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8(+) tumor-associated lymphocytes and poor prognosis in prostate cancer","volume":"144","author":"Mo","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0057","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.19.01598","article-title":"Phase IB\/II trial of lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma, endometrial cancer, and other selected advanced solid tumors","volume":"38","author":"Taylor","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0058","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0059","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/annrheumdis-2019-215743","article-title":"Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population","volume":"79","author":"Kishikawa","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anl.2023.08.006_bib0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2021-220687","article-title":"Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese","volume":"80","author":"Tomofuji","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anl.2023.08.006_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.585973","article-title":"A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology","volume":"10","author":"Kishikawa","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.anl.2023.08.006_bib0062","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system","volume":"17","author":"Levy","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.anl.2023.08.006_bib0063","article-title":"OMARU: a robust and multifaceted pipeline for metagenome-wide association study","volume":"4","author":"Kishikawa","year":"2022","journal-title":"NAR Genom Bioinformat"},{"key":"10.1016\/j.anl.2023.08.006_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2014.00209","article-title":"An introduction to the analysis of shotgun metagenomic data","volume":"5","author":"Sharpton","year":"2014","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.anl.2023.08.006_bib0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transd Targeted Ther"},{"key":"10.1016\/j.anl.2023.08.006_bib0066","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-022-00381-5","article-title":"Intratumor microbiome in cancer progression: current developments, challenges and future trends","volume":"10","author":"Liu","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0067","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.anl.2023.08.006_bib0068","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.anl.2023.08.006_bib0069","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.anl.2023.08.006_bib0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","article-title":"Targeting the gut microbiota for cancer therapy","volume":"22","author":"Fernandes","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0071","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.3390\/cancers14174116","article-title":"A review of the role of oral microbiome in the development, detection, and management of head and neck squamous cell cancers","volume":"14","author":"Burcher","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2023.08.006_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102442","article-title":"The microbiota and radiotherapy for head and neck cancer: what should clinical oncologists know?","volume":"109","author":"Reis Ferreira","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.anl.2023.08.006_bib0073","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01068-22","article-title":"Multi-omics integration reveals the crucial role of Fusobacteriumin the inflammatory immune microenvironment in head and neck squamous cell carcinoma","volume":"10","author":"Qiao","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.anl.2023.08.006_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00476","article-title":"The oral microbiota may have influence on oral cancer","volume":"9","author":"Zhang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.anl.2023.08.006_bib0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0394632015586144","article-title":"The prevalence rate of Porphyromonas gingivalis and its association with cancer: a systematic review and meta-analysis","volume":"28","author":"Sayehmiri","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.anl.2023.08.006_bib0076","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","article-title":"A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors","volume":"185","author":"Dohlman","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.anl.2023.08.006_bib0077","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/odi.12565","article-title":"Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects","volume":"22","author":"Alnuaimi","year":"2016","journal-title":"Oral Dis"},{"key":"10.1016\/j.anl.2023.08.006_bib0078","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jop.13298","article-title":"Candida albicans induces upregulation of programmed death ligand 1 in oral squamous cell carcinoma","volume":"51","author":"Wang","year":"2022","journal-title":"Journal of Oral Pathology & Medicine"},{"key":"10.1016\/j.anl.2023.08.006_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106305","article-title":"Oral microbiome and risk of incident head and neck cancer: a nested case-control study","volume":"137","author":"Wu","year":"2023","journal-title":"Oral Oncol."},{"key":"10.1016\/j.anl.2023.08.006_bib0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jamaoncol.2017.4777","article-title":"Association of oral microbiome with risk for incident head and neck squamous cell cancer","volume":"4","author":"Hayes","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105657","article-title":"Dysbiotic tumor microbiota associates with head and neck squamous cell carcinoma outcomes","volume":"124","author":"Dou","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0082","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.anl.2023.08.006_bib0083","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/0008-5472.CAN-07-3212","article-title":"Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells","volume":"68","author":"Kobayashi","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0084","doi-asserted-by":"crossref","first-page":"21530","DOI":"10.1038\/s41598-020-78560-3","article-title":"Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.anl.2023.08.006_bib0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-21-4316","article-title":"Association of TP53 and CDKN2A mutation profile with tumor mutation burden in head and neck cancer","volume":"28","author":"Deneka","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0086","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41590-020-0628-2","article-title":"Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection","volume":"21","author":"Schober","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.anl.2023.08.006_bib0087","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040781","article-title":"Prognostic significance of CD4+ and CD8+ tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: a meta-analysis","volume":"13","author":"Borsetto","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2023.08.006_bib0088","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-22-1987","article-title":"Safety and efficacy of MEDI0457 plus durvalumab in patients with human papillomavirus-associated recurrent\/metastatic head and neck squamous cell carcinoma","volume":"29","author":"Aggarwal","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0089","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41591-019-0434-2","article-title":"Immunogenic neoantigens derived from gene fusions stimulate T cell responses","volume":"25","author":"Yang","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0090","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1568813","article-title":"Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma","volume":"8","author":"Ren","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.anl.2023.08.006_bib0091","first-page":"132","article-title":"PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors","author":"Duhen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anl.2023.08.006_bib0092","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1958589","article-title":"Integrating CD4(+) T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model","volume":"10","author":"Shibata","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.anl.2023.08.006_bib0093","doi-asserted-by":"crossref","first-page":"534","DOI":"10.18632\/oncotarget.27907","article-title":"Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma","volume":"12","author":"Schutt","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2023.08.006_bib0094","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/bjc.2013.577","article-title":"EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy","volume":"109","author":"Kumai","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0095","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1038\/srep16280","article-title":"Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma","volume":"5","author":"Kumai","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.anl.2023.08.006_bib0096","article-title":"Antitumor peptide-based vaccine in the limelight","volume":"10","author":"Kumai","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.anl.2023.08.006_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.957580","article-title":"A phase II study evaluating the interest to combine UCPVax, a telomerase CD4 T(H)1-inducer cancer vaccine, and atezolizumab for the treatment of HPV positive cancers: volatil study","volume":"12","author":"Rebucci-Peixoto","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0098","doi-asserted-by":"crossref","first-page":"36956","DOI":"10.1038\/srep36956","article-title":"PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.anl.2023.08.006_bib0099","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1349-7006.2012.02248.x","article-title":"Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck","volume":"103","author":"Chikamatsu","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2023.08.006_bib0100","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1111\/cas.15081","article-title":"Improving function of cytotoxic T-lymphocytes by transforming growth factor-beta inhibitor in oral squamous cell carcinoma","volume":"112","author":"Kondo","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2023.08.006_bib0101","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hed.20490","article-title":"Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck","volume":"29","author":"Chikamatsu","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.08.006_bib0102","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1158\/1078-0432.CCR-07-1403","article-title":"The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck","volume":"13","author":"Strauss","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \"biological missile\" for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.anl.2023.08.006_bib0104","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0105","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/hed.26885","article-title":"Phase 1\/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma","volume":"43","author":"Cognetti","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.08.006_bib0106","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s10147-021-01960-6","article-title":"A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma","volume":"26","author":"Tahara","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.anl.2023.08.006_bib0107","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.18632\/oncotarget.14425","article-title":"Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity","volume":"8","author":"Ogawa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2023.08.006_bib0108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.anl.2023.08.006_bib0109","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.anl.2023.08.006_bib0110","doi-asserted-by":"crossref","first-page":"352ra110","DOI":"10.1126\/scitranslmed.aaf6843","article-title":"Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy","volume":"8","author":"Sato","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0111","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1021\/acs.bioconjchem.9b00547","article-title":"The effect of antibody fragments on CD25 targeted regulatory T cell near-infrared photoimmunotherapy","volume":"30","author":"Okada","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.anl.2023.08.006_bib0112","article-title":"Local depletion of immune checkpoint ligand CTLA4 expressing cells in tumor beds enhances antitumor host immunity","volume":"4","author":"Okada","year":"2021","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.anl.2023.08.006_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103345","article-title":"Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials","volume":"67","author":"Okada","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.anl.2023.08.006_bib0114","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1158\/1535-7163.MCT-21-0470","article-title":"Simultaneously combined cancer cell- and CTLA4-targeted NIR-PIT causes a synergistic treatment effect in syngeneic mouse models","volume":"20","author":"Kato","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.anl.2023.08.006_bib0115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.anl.2023.08.006_bib0116","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003036","article-title":"Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity","volume":"9","author":"Taki","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.anl.2023.08.006_bib0117","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/15384047.2019.1617566","article-title":"Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma","volume":"20","author":"Watanabe","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anl.2023.08.006_bib0118","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1158\/1535-7163.MCT-22-0313","article-title":"Near-infrared photoimmunotherapy targeting podoplanin-expressing cancer cells and cancer-associated fibroblasts","volume":"22","author":"Kato","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.anl.2023.08.006_bib0119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030707","article-title":"Podoplanin in inflammation and cancer","volume":"20","author":"Quintanilla","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anl.2023.08.006_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041019","article-title":"Targeted phototherapy for malignant pleural mesothelioma: near-infrared photoimmunotherapy targeting podoplanin","volume":"9","author":"Nishinaga","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.anl.2023.08.006_bib0121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.01.027","article-title":"Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model","volume":"84","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.anl.2023.08.006_bib0122","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-023-03460-0","article-title":"Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer","author":"Yamaki","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.anl.2023.08.006_bib0123","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13071174","article-title":"Immune status of cervical lymph nodes in head and neck cancer-a surgical oncology perspective","volume":"13","author":"Nakamura","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.anl.2023.08.006_bib0124","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1158\/1078-0432.CCR-20-1695","article-title":"Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus-unrelated head and neck cancer: a multicenter, phase II trial","volume":"26","author":"Uppaluri","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:42:16Z","timestamp":1759952536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814623001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0385814623001529"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2023.08.006","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational research in head and neck cancer: Molecular and immunological updates","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2023.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}